ProCE Banner Activity

A Look Ahead to the 2020 SABCS Virtual Symposium

Conference Coverage
Clinical Thought
Experts highlight key data to help you prepare for what to expect at the upcoming 2020 SABCS Virtual Symposium.

Released: December 04, 2020

Expiration: December 03, 2021

No longer available for credit.

Share

Faculty

Sara Hurvitz

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Puma Biotechnology, Inc.

Seagen

Faculty Disclosure

Primary Author

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Sara Hurvitz, MD, FACP, has disclosed that she has received funds for research support (paid to institution) from Ambrx, Amgen, Arvinas, Bayer, Daiichi Sankyo, Dignitana, Genentech, GlaxoSmithKline, Immunomedics, Lilly, MacroGenics, Novartis, OBI Pharma, Pfizer, Pieris, Puma, Radius, Roche, Sanofi, Seattle Genetics, and Zymeworks and funds for travel support from Lilly.